Major FoB Collaborations [New detail for ACT (f/k/a WPI)-AMGN collaboration; new table entry for Procognia-UTR.] [pre] Date Targets iHub References Catalent-UMN 12/12 Asia #msg-82556713 Merck KGaA-RDY 6/12 oncology #msg-76359649 Daiichi-Coherus 5/12 * #msg-75397629 Fujifilm-Kyowa 3/12 Humira #msg-73800486 ACT-Bioton 2/12 insulin #msg-74987123 ACT-AMGN 12/11 † #msg-83846381, #msg-70101928 BAX-MNTA 12/11 various #msg-70212854, #msg-70258421 Samsung-BIIB 12/11 various #msg-69629103, #msg-80622249 MRK-Hanwha 6/11 Enbrel #msg-64164954, #msg-64193403 MYL-Biocon 6/09 various #msg-39119393, #msg-72421544 TEVA-Lonza 1/09 various #msg-34930012, #msg-80236315 Procognia-UTR n/a Humira #msg-84340976[/pre]*Enbrel and Rituxan in selected Asian countries. †Humira, Remicade, Heceptin, Avastin, Rituxan, Erbitux. [/pre]